Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002276:Carcinoid Tumor / Q000188:drug therapy; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced* / Q000150:complications; D007093:Imidazoles / Q000009:adverse effects*; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D014511:Uremia / Q000139:chemically induced* / Q000150:complications; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D016898:Interferon-alpha; D000077211:Zoledronic Acid